Informações:
Falhas:
ID
21499
Descrição
NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: HIV associated conditions Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV
Palavras-chave
Versões (1)
- 25/04/2017 25/04/2017 -
Transferido a
25 de abril de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Genetic Screening For HLA-B*5701 in Patients with HIV HIV associated conditions NCT00340080
Genetic Screening For HLA-B*5701 HIV associated conditions NCT00340080
Similar models
Genetic Screening For HLA-B*5701 HIV associated conditions NCT00340080
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Did the subject experience any HIV-associated conditions after Screening
text
C0276555 (UMLS CUI [1])
Code List
Did the subject experience any HIV-associated conditions after Screening
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Bacillary angiomatosis (B1)
CL Item
Candidiasis, oropharyngeal (thrush) (B2)
CL Item
Candidiasis, vulvovaginal; persistent, frequent or poorly responsive to therapy (B3)
CL Item
Cervical dysplasia (moderate or severe)/cervical carcinoma in situ (B4)
CL Item
Constitutional symptoms, such as fever (38.5 C) or diarrhea lasting greater than 1 month (B26)
CL Item
Hairy leukoplakia, oral (B7)
CL Item
Herpes zoster (shingles), involving at least two distinct episodes or more than one dermatome (B8)
CL Item
Idiopathic thrombocytopenic purpura (B9)
CL Item
Listeriosis (B10)
CL Item
Pelvic inflammatory disease, particularly if complicated by tubo-ovarian abscess (B11)
CL Item
Peripheral neuropathy (B12)
CL Item
Other, specify in table. (BOT)
CL Item
Candidiasis of bronchi, trachea, or lungs (C1)
CL Item
Candidiasis, esophageal (C2)
CL Item
Cervical cancer, invasive (C3)
CL Item
Coccidioidomycosis, disseminated or extrapulmonary (C4)
CL Item
Cryptococcosis, extrapulmonary (C5)
CL Item
Cytomegalovirus disease (other than liver, spleen, or nodes) (C7)
CL Item
Cytomegalovirus retinitis (with loss of vision) (C8)
CL Item
Encephalopathy, HIV-related (C9)
CL Item
Herpes simplex: chronic ulcer(s) (greater than 1 month’s duration); or bronchitis, pneumonitis, or esophagitis (C10)
CL Item
Histoplasmosis, disseminated or extrapulmonary (C11)
CL Item
Isosporiasis, chronic intestinal (greater than 1 month’s duration) (C12)
CL Item
Kaposi’s sarcoma (C29)
CL Item
Lymphoma, Burkitt’s (or equivalent term) (C15)
CL Item
Lymphoma, immunoblastic (or equivalent term) (C16)
CL Item
Lymphoma, primary, of brain (C17)
CL Item
Mycobacterium avium complex or M. kansasii, disseminated or extrapulmonary (C18)
CL Item
Mycobacterium tuberculosis, any site (pulmonary or extrapulmonary) (C19)
CL Item
Mycobacterium, other species or unidentified species, disseminated or extrapulmonary (C20)
CL Item
Pneumocystis carinii pneumonia (C21)
CL Item
Pneumonia, recurrent (C22)
CL Item
Progressive multifocal leukoencephalopathy (C23)
CL Item
Salmonella septicemia, recurrent (C24)
CL Item
Toxoplasmosis of brain (C25)
CL Item
Wasting syndrome due to HIV (C26)
CL Item
Cryptosporidiosis, chronic intestinal (greater than 1 month’s duration) (C31)
HIV-Associated Conditions
Item
HIV-Associated Conditions Other text
text
C0276555 (UMLS CUI [1])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0276555 (UMLS CUI [1,2])
C0276555 (UMLS CUI [1,2])
Item
Has the subject previously had this condition?
text
C0276555 (UMLS CUI [1])
CL Item
Yes (Y)
CL Item
No (N)